Log in to save to my catalogue

Retracted: Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activa...

Retracted: Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10791279

Retracted: Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation

About this item

Full title

Retracted: Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation

Publisher

United States: Hindawi

Journal title

Oxidative medicine and cellular longevity, 2024, Vol.2024, p.1-1

Language

English

Formats

Publication information

Publisher

United States: Hindawi

Subjects

Subjects and topics

More information

Scope and Contents

Contents

[This retracts the article DOI: 10.1155/2022/9139338.].

Alternative Titles

Full title

Retracted: Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10791279

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10791279

Other Identifiers

ISSN

1942-0900

E-ISSN

1942-0994

DOI

10.1155/2024/9846960

How to access this item